Skip to main content
SpringerLink
Log in

Advances in Alliteration in Acute Myocardial Infarction: From “Time to Treatment” to “Onset to Opening”

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Simoons ML, Serruys PW, van den Brand M, et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomized trial by the Interuniversity of Cardiology Institute in the Netherlands. Lancet 1985;2:578-581.

    Google Scholar 

  2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.

    Google Scholar 

  3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.

    Google Scholar 

  4. ASSET Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;2:525-530.

    Google Scholar 

  5. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded? Circulation 1989;79:441-444.

    Google Scholar 

  6. Grines CL, Weaver DW. Treating myocardial infarction: Importance of early reperfusion. Lancet 1994;344:490-491.

    Google Scholar 

  7. Cannon CP, Antman EM, Walls R, Braunwald E. Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombolysis 1994;1:27-34.

    Google Scholar 

  8. Pell ACH, Miller HC, Robertson CE, Fox KAA. Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. Br Med J 1992;304:83-7.

    Google Scholar 

  9. National Heart Attack Alert Program Coordinating Committee — 60 Minutes to Treatment Working Group. Emergency department: Rapid identi~cation and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994;23:311-329.

    Google Scholar 

  10. Lambrew CT. Emergency Department triage of patients with nontraumatic chest pain. ACC Curr J Rev 1995;4: 61-62.

    Google Scholar 

  11. Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction. Drugs 1992;44:293-325.

    Google Scholar 

  12. The GUSTO Angiographic Investigators. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-1622.

    Google Scholar 

  13. Cannon CP, McCabe CH, Diver DJ, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol 1994;24:1602-1610.

    Google Scholar 

  14. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.

    Google Scholar 

  15. Topol EJ, Califf RM, Lee KL, on behalf of the GUSTO Investigators. More on the GUSTO trial [letter]. N Engl J Med 1994;331:277-278. Published errata appear in N Engl J Med 1994;331:687, and 1994;331:1323.

    Google Scholar 

  16. Cannon CP, Braunwald E. Time to reperfusion: The critical modulator in thrombolysis and primary angioplasty. J Thromb Thrombolysis 1996;3:109-117.

    Google Scholar 

  17. Cannon CP, Lambrew CT, Tiefenbrunn AJ, et al. Influence of door-to-balloon time on Mortality in Primary Angioplasty Results in 3,648 patients in the Second National Registry of Myocardial Infarction (NRMI-2) (abstrt). J AmColl Cardiol 1996;27(Suppl. A):61A-62A.

    Google Scholar 

  18. Caputo RP, Ho KK, Stoler RC, et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1997;79:1159-1164.

    Google Scholar 

  19. Patel S, Reese C, O'Connor RE, Doorey AJ. Adverse outcomes accompanying primary angioplasty (PTCA) for acute myocardial infarction (AMI)-dangers of delay (abstrt). J Am Coll Cardiol 1996;27(Suppl. A):62A.

  20. Berger PB, Holmes DR, Califf RM, Criger DA. Hospital delay in achieving reperfusion with direct PTCA in GUSTOIIb: Relationship to 30-day mortality. (Abstract) Circulation 1997;96(Supp. 1):I-531.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston

    Christopher P. Cannon & Mark Smith

  2. Massachusetts and Department of Emergency Medicine, Washington Hospital Center, Washington, D.C.

    Christopher P. Cannon

Authors
  1. Christopher P. Cannon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cannon, C.P., Smith, M. Advances in Alliteration in Acute Myocardial Infarction: From “Time to Treatment” to “Onset to Opening”. J Thromb Thrombolysis 6, 5–7 (1998). https://doi.org/10.1023/A:1008818103943

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008818103943

Keywords

Search

Navigation